Lucía Núñez Selected Research

Lucía Núñez Research Topics

Disease

11	Neoplasms (Cancer) 10/2021 - 09/2004
7	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 07/2008
7	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2006
5	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 10/2014
3	Heart Failure 01/2018 - 01/2016
2	Cognitive Dysfunction 02/2015 - 07/2008
2	Cardiac Arrhythmias (Arrythmia) 04/2007 - 03/2005
1	Nerve Degeneration 05/2022
1	Tetraploidy 11/2021
1	Heart Diseases (Heart Disease) 03/2021
1	Confusion (Bewilderment) 03/2021
1	Chronic Renal Insufficiency 03/2021
1	Neuroinflammatory Diseases 01/2021
1	Dementia (Dementias) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 04/2017
1	Ulcerative Colitis 01/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2015
1	Adenoma (Adenomas) 01/2015
1	Hypopituitarism (Sheehan's Syndrome) 01/2015
1	Parkinson Disease (Parkinson's Disease) 05/2012
1	Leukemia 05/2011
1	Necrosis 04/2011
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 04/2010
1	Atrial Fibrillation 12/2008
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2008
1	Brugada Syndrome 08/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2007
1	Atherosclerotic Plaque (Atheroma) 04/2007

Drug/Important Bio-Agent (IBA)

7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 05/2011
5	Amyloid (Amyloid Fibrils)IBA 05/2022 - 01/2012
5	CalciumIBA 06/2017 - 09/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2017 - 01/2016
2	SalicylatesIBA 06/2017 - 02/2006
2	NeurotoxinsIBA 01/2017 - 01/2016
2	Peptides (Polypeptides)IBA 01/2016 - 01/2012
2	Hormones (Hormone)IBA 01/2015 - 09/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2021
1	GalactosidasesIBA 11/2021
1	NocodazoleIBA 11/2021
1	Chimeric Antigen ReceptorsIBA 10/2021
1	Urea (Carbamide)FDA LinkGeneric 03/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Toll-Like Receptor 4IBA 01/2020
1	PolyaminesIBA 01/2019
1	Eflornithine (Ornidyl)FDA Link 01/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 04/2017
1	Anthocyanins (Anthocyanin)IBA 04/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2017
1	Interleukin-33IBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	IvabradineIBA 01/2016
1	Growth Hormone (Somatotropin)IBA 01/2015
1	Pituitary Hormone-Releasing HormonesIBA 01/2015
1	Stromal Interaction Molecule 2IBA 10/2014
1	Transient Receptor Potential ChannelsIBA 10/2014
1	Phosphotransferases (Kinase)IBA 05/2012
1	BuffersIBA 05/2011
1	Lipid Bilayers (Lipid Bilayer)IBA 04/2011
1	elisidepsinIBA 04/2011
1	Carrier Proteins (Binding Protein)IBA 04/2010
1	Myosins (Myosin)IBA 04/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2008
1	Calcium Channels (Calcium Channel)IBA 08/2008
1	SodiumIBA 08/2008
1	amyloid beta-protein (1-42)IBA 07/2008
1	Amyloid beta-PeptidesIBA 07/2008
1	AequorinIBA 07/2008
1	AntioxidantsIBA 04/2007
1	oxidized low density lipoproteinIBA 04/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2007
1	Irbesartan FDA LinkGeneric 03/2005
1	Spironolactone (Aldactone)FDA LinkGeneric 03/2005
1	candesartanIBA 03/2005
1	Canrenoic Acid (Potassium Canrenoate)IBA 03/2005
1	Angiotensin IIIBA 03/2005
1	Losartan (Cozaar)FDA LinkGeneric 03/2005
1	Mineralocorticoid Receptor AntagonistsIBA 03/2005
1	eprosartan (Teveten)FDA Link 03/2005
1	Pituitary Hormone-Regulating Hormone ReceptorsIBA 09/2004

Therapy/Procedure

3	Chemoprevention 01/2019 - 01/2016
2	Heart Transplantation (Grafting, Heart) 01/2018 - 01/2018
1	Immunotherapy 10/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021
1	Therapeutics 04/2017
1	Patient Readmission 01/2016